• Scientists, in a study published online in the journal Cell, found that the BQ and XBB subvariants are “barely susceptible to neutralization” by the vaccines, including the new omicron boosters.
  • This could result in a surge of breakthrough infections and reinfections, though the vaccines have been shown to hold up against severe disease, they wrote.
  • Key antibody drugs, Evusheld and bebtelovimab, were “completely inactive” against the new subvariants, according to the study.

https://www.cnbc.com/2022/12/14/covid-news-bq-xbb-omicron-subvariants-pose-serious-threat-to-boosters.html